IDM Pharma (IDMI) Reports Q4 Loss of $0.07
More News related to IDMI
- Unusual 11 Mid-Day Movers 5/18: KONA, IDMI, GRO, REDF Higher; SPIR, EDZ, COIN, FAZ Lower
- Notable Mergers and Acquisitions of the Day 5/18: KONA, IDMI, CF/AGU, VR/IPCR, AMSWA/LGTY
- Morning Movers 5/18: KONA, AHR, IDMI, LGTY, IBN, HEB Higher; SPIR, COIN, BIDZ, AYE Lower
- Takeda To Acquire IDM Pharma (IDMI) at 55% Premium
- IDM Pharma (IDMI) Reports Q4 Loss of $0.07
More News related to Earnings
- Notable Analyst Ratings Changes 11/25: EXXI, IWA, VPRT Upgraded; BNHN, NRG, GTE Downgraded
- Notable Mergers and Acquisitions of the Day 11/25: PEET/DDRX/GMCR, ERIC, URX
- Morning Movers 11/25: RTK, QADI, GGR, HEV, CAEI Higher; BNHN, DRAM, CWTR, CONN Lower
- After-Hours Movers 11/24: QADI, JCG, ASYS Higher; DRAM, CWTR Lower
- Trading Radar for 11/25: Deere & Co. (DE), Tiffany & Co. (TIF), Conn's (CONN) Report
IDM Pharma, Inc. (Nasdaq: IDMI) reports Q4 loss of $0.07, compared to a net loss of $0.11 in the same quarter last year. Revenue for the quarter was $300K, versus $5.6 million in Q407.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
